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| INTRODUC TI ON
With the development of geriatric medicine, more and more reported research has found that as humans grow old, their blood vessels also age. Blood vessels are vital components of various organs. Vascular aging is an important physiological and pathological basis for the aging of organs and systems of the human body and is the common pathogenesis of various chronic diseases in the elderly. Along with the aging of population, the morbidity of vascular-related diseases is extremely high among the elderly. 1 Early detection of vascular aging and the use of correct methods to delay and treat vascular aging are of great significance to prevent and control chronic diseases in the elderly and to deal with the increasingly serious problems of population aging. For this purpose, this consensus is formulated for use by geriatric doctors and related personnel. This consensus mainly introduces the contents of aging of arterial blood vessels.
| DEFINITI ON OF VA SCUL AR AG ING
Morphologically, aging blood vessels represent increased deposition of collagen fibers, increased and disordered elastic fibers, disorganized arrangement of smooth muscle cells, and incrassated intima. Functionally, aging blood vessels show increased stiffness, decreased sensitivity to vasodilator factors, increased sensitivity to vasoconstrictor factors, and decreased angiogenesis. Vascular aging increases the susceptibility of hypertension and atherosclerosis.
| MECHANIS M OF VA SCUL AR AG ING
Vascular aging is the outcome of the aging of vascular endothelial cells and smooth muscle cells. Cell senescence is regulated by both environment and gene. For the cell itself, two kinds of vascular cells may undergo replicative senescence and induced senescence in vivo.
Replicative senescence may be the results of cellular fission caused by vascular damage and repair, while induced senescence may be associated with the accumulation of harmful components in the blood.
At the level of vascular tissue, stem cells may be involved in the replacement of damaged and senescent cells. If stem cells are depleted and the self-renewing ability of endothelial cells and smooth muscle cells is depressed, vascular aging may occur. 2 
| VA SCUL AR AG ING -REL ATED D IS E A S E S
With the aging of the elderly without obvious diseases, the arteries may acquire enlarged lumen, intima-media thickness (IMT), increased vascular stiffness, increased systolic blood pressure, decreased diastolic blood pressure, and increased pulse pressure, which may lead to vascular endothelial dysfunction and other changes in vascular aging. Those changes, occurring earlier than clinical manifestations, are high-risk factors for vascular aging-related diseases, such as atherosclerosis, hypertension, heart, brain, and kidney vascular disease and peripheral vascular disease (PAD). Vascular aging interacts with vascular diseases and provides an environment for the occurrence and development of vascular diseases, which in turn accelerate the process of vascular aging.
| Early vascular aging
Early vascular aging (EVA) refers to the occurrence of arteriosclerosis and atherosclerosis with earlier age, aggravated degree, and a process faster than the normal aging, which overlap together to accelerate the occurrence and development of vascular aging, leading to early cardiovascular disease (CVD), stroke and PAD, 3 that is, the cardiovascular chain of aging. 4 EVA is an independent predictor of cerebrovascular diseases, cardiovascular death, and all-cause death.
Two standard deviations of age-corrected pulse wave velocity (PWV) values greater than the normal reference values of healthy people are usually used as EVA criteria. 3 A community population study showed that: the incidence of EVA was 12.5%, 26.1% of individuals aged younger than 30 years presented EVA, and it was more common in young men. 5 During initial visits, the following patients should be evaluated 
| Vascular calcification
Vascular calcification is the deposition of ectopic calcium in vascular sites, a phenotype of vascular aging. An epidemiological investigation showed that 93% of men and 75% of women aged over 70 years shown that intimal calcification, which occurs and develops in atherosclerotic plaques, can play an important role in stabilizing the plaques as the degree of calcification deepens. Therefore, there are still many controversies as to whether vascular calcification is the pathological result of body and blood vessels in the aging and pathological environment, or a mechanism of self-compensation and selfprotection of the body or blood vessels.
| Vascular aging-related cardiac changes
Aging can cause left ventricular hypertrophy, atrial fibrillation, and heart-failure-related cardiac changes. 10 The 
| Hypertension
Interaction between vascular aging and hypertension leads to EVA and arteriosclerosis, which is an independent risk factor for cardiovascular events. Arteriosclerosis and hypertension are mutual cause and effect. On the one hand, hypertension causes damage to the arterial wall, leading to arteriosclerosis. On the other hand, arteriosclerosis itself is the main cause of increased systolic blood pressure, especially in elderly people. 11
| Vascular aging is the predictor and risk factor for hypertension
Brachial-ankle PWV (baPWV) and carotid-femoral PWV (cfPWV) are associated with elevated systolic blood pressure and hypertension. The increase in aortic stiffness, forward pressure wave amplitude, augmentation index, and carotid stiffness increases the risk of hypertension in the future. The decline in elasticity of large arteries and small arteries is associated with hypertension, suggesting that vascular aging indicators precede and promote the occurrence and development of clinical hypertension. 12
| Hypertension promotes vascular aging
Age and blood pressure are independently associated with PWV.
Blood pressure is an important risk factor for arteriosclerosis.
Increased blood pressure leads to increased arterial stiffness. In patients with hypertension who were followed up for 6-year medication, the annual increase rate of PWV was still significantly higher than that in normal blood pressure, 13 indicating that hypertension can accelerate EVA.
| Vascular aging is one of the causes of residual risk of CVD
Niiranen et al 14 pointed out that regardless of whether blood pressure is controlled, most patients with treated hypertension in the community had higher PWV than normal, and the incidence of cardiovascular events remains high. Hypertensive patients treated with antihypertensive drugs still have 50% of residual risk of CVD.
| Kidney disease
The small blood vessels of the kidney have small resistance and fast blood flow so pulsation could pump more blood into the smallest blood vessels of the kidney, leading to microvascular damage (small artery wall extension, small aneurysm rupture and microthrombosis, etc.), further causing pulse wave nephropathy and resulting in the occurrence of end-stage renal disease. 15
| Relationship between vascular aging and renal dysfunction in CKD
The increase of each standard deviation of pulse pressure or arterial stiffness causes a drop of estimated glomerular filtration rate/y of 0.15 mL·min −1 ·1.73 m −2 and 0.08 mL·min −1 ·1.73 m −2 , respectively, and the risk of CKD increases by 11% and 13%, respectively.
Also, the risk of CKD increases by 7% for the rise of each standard deviation of PWV. These results suggest that the increase of arteriosclerosis index is related to the decline of renal function. 16 Kong et al 17 indicated that every 100 cm/s increase in cfPWV and cfPWV at the highest quartile increases the risk of proteinuria by 15% and 93%, respectively, but this is not related to the estimated glomerular filtration rate.
| Vascular aging is a predictor and risk factor for CVD in CKD
The cfPWV of patients with stage 2-5 CKD is higher than those with hypertension and normal blood pressure. The increase of arterial diameter, arterial stiffness, and arterial wall stress is respectively parallel to the decline of estimated glomerular filtration rate in patients. The degree of aortic sclerosis in patients with CKD is significantly higher than in hypertensive and healthy subjects. 4, 18 Arteriosclerosis is common in end-stage renal disease, and the incidence of plaque calcification is high. Aortic stiffness increases in patients with end-stage renal disease. In patients with mild to severe renal dysfunction, increased central arterial stiffness is related to decreased creatinine clearance. 19 Increased arterial stiffness is an independent predictor of CVD in hemodialysis patients.
Arterial stiffness can predict CVD risk and all-cause mortality in patients with CKD undergoing peritoneal dialysis, kidney transplantation, or non-dialysis. 20
| Cerebrovascular disease
Vascular aging leads to the development of hemodynamic aging syndrome. 3 Like the mechanism of pulse wave nephropathy, high pulsating blood flow into the small blood vessels of the brain can cause cerebral microvascular damage (small artery wall extension, small aneurysm rupture and microthrombosis, etc.) and cerebral vascular aging, further causing pulse wave encephalopathy and resulting in cerebrovascular disease and cognitive impairment.
| Stroke
The baseline cfPWV in patients with essential hypertension has a predictive value for stroke. 21 Arteriosclerosis is an independent predictor of stroke in healthy subjects. 22 Vascular aging is also a prognostic indicator of stroke. Low cfPWV is associated with a good prognosis for stroke. Aortic PWV in stroke patients can predict asymptomatic coronary artery disease, and its ability to predict is superior to that of traditional risk factors. 23 Acute ischemic stroke and lacunar infarction are associated with 
| Peripheral arterial disease
An increase in arterial stiffness due to vascular aging is a risk factor for PAD and CVD, and a predictor for PAD and cardiovascular and all-cause mortality. Xu et al 27 reported that baPWV is a substitute index for target organ damage and a predictive parameter for PAD.
A baPWV > 2100 cm/s is related to potential PAD. Kals et al 28 
| Framingham blood vessel age evaluation formula
The Framingham Heart Study revolves around 8491 subjects and was followed up for 12 years. The cardiovascular age formula was established based on risk factors for cardiovascular events, such as male sex, hyperlipidemia, hypertension, diabetes, and smoking. The concept of blood vessel age was proposed and is still widely used today. The assessment of clinical vascular age guides cardiovascular risk prevention, and the Framingham vascular age assessment formula is described in detail in the report by D'Agostino et al. 32 
| Non-invasive detection of vascular function and structure

| PWV
PWV is the conduction velocity of the arterial pulsation wave from the proximal to the telecentric end along the arterial wall when the heart pumps blood. By measuring the ratio of the distance between the two recorded sites and the pulse wave transit time, the formula is: PWV (cm/s) = L/t, where distance L is the distance between the two probes, and propagation time t is the time difference between the two waveforms. PWV is based on the mechanism that the conduction velocity of the blood (pulse wave) generated by the heart when the arteriosclerosis is accelerated, and the higher the degree of arterial stiffness, the larger the PWV. With age, the elastic component of the aorta decreases, the wall thickens, the arteries expand progressively, the arterial stiffness increases, and the PWV increases. The central elastic artery increases more with age compared with the peripheral arteries, and PWV is positively correlated with the Framingham score. 33 It has predictive value for the diagnosis of coronary heart disease. 34 The cfPWV is a gold index for evaluating PWV. However, due to its complicated operation, the baPWV is often used to measure the stiffness of the aorta and middle artery. A greater baPWV value indicates stiffer arteries. According to the change of normal range of different ages and sexes, the baPWV of healthy volunteers under 60 years old in China is less than 1400 cm/s. 35 
| Arterial blood-flow-mediated vasodilation
The principle of vasodilation is to measure the temporal change of the radial artery diameter under the action of shear stress, that is, to fix the inflatable cuff to the forearm (the distal end of the ultrasound probe). Exceeding the systolic pressure for 5 minutes, and then letting off the gas in the cuff, the sudden increase of blood flow in the radial artery after deflation produces shear stress on the vessel wall.
This shear stress will activate the production of nitric oxide (NO) in the vascular endothelial cells to release NO. The permeation of NO in the VSMCs causes relaxation of smooth muscle cells to expand the blood vessels, and the diameter change of vasodilation after reactive hyperemia is used as an evaluation index. 36 
| Intima-media wall
The intima-media wall is the distance between the arterial lumen- 
| Lifestyle improvement
| Diet
A healthy diet is recommended because it is proved to be beneficial to vascular health. Based on 2016 dietary guidelines for Chinese, it is recommended to eat multiple foods and cereal is dominant; eat more vegetables, fruits, milk and soy; eat a proper amount of fish, poultry, eggs and lean meat; decrease the intake of salt and oil and limit consumption of sugar and alcohol. The collocation of various nutrients can refer to the meal plate. The meal plate is divided into four parts: cereal and potato, animal food, vegetables, and fruits. Among them, vegetables and cereal should account for the largest proportion of the area, while animal food, which provides protein, should account for the least.
Calorie-restricted diet is currently the most recognized measure to prolong the life cycle of an organism. The mechanism of calorie-limited diet includes insulin/IGF-1 pathway, sirtuin pathway, TOR pathway, multipath interventions for DNA repair and even intestinal flora. 44 However, there is no effective clinical data in specific clinical practice and the control of calorie intake should be adhered to for a long term.
| Weight control
Obesity is an independent risk factor for vascular diseases. 45 and waist circumference (<90 cm for men and <85 cm for women) is recommended.
| Smoking cessation
Smoking accelerates vascular aging and is closely related to atherosclerosis, while smoking cessation can reduce the risk of vascular diseases. Everyone can benefit from smoking cessation, so all smokers should be advised to give up.
| Physical activity
Physical activity can improve vascular function and delay vascular aging. Aerobic physical activity benefits blood vessels the most, which can improve arterial compliance, reduce arterial stiffness, and restore vascular elasticity. From a more microscopic perspective, it can mobilize endothelial progenitor cells and enhance the endogenous vascular repair activity of endothelial progenitor cells, thus improving vascular endothelial function and preventing vascular aging. Drug therapy combined with exercise training can improve 6 minutes' walking distance better than drug therapy combined with endovascular treatment. 46 The effects of physical activity on the body come from multiple pathways, including the sirtuin signaling pathway. 47 For the elderly, physical activity must be moderate. In recent years, with the development of rehabilitation medicine, the exercise prescription has attracted more and more attention. Putting forward the individualized exercise prescription according to each person's own characteristics is of great significance to prevent vascular aging. The heart rate reserve method and subjective fatigue grading method can be used to determine exercise intensity combined with subjective feeling.
Frequently used aerobic exercises are walking, jogging, cycling, swimming, body building exercise, as well as walking on instruments, treadmills, boating, and so on. It is recommended to start from 20 minutes and gradually increase to 40-60 minutes, with the physical activity frequency of 3-7 times per week.
| Drug
| Drugs aiming at risk factors
Traditional drugs to treat risk factors have been found to improve vascular function, reduce arterial stiffness, and delay vascular aging, such as blood-pressure-lowering drugs (aimed at hypertension), angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, spironolactone, statins, and hypoglycemic drugs of thiazolidinediones. 48 On the one hand, the anti-vascular aging effects of these drugs are attributed to the benefits of controlling risk factors; on the other hand, some of these drugs can directly improve vascular function and delay vascular aging. Like angiotensin converting enzyme inhibitors, angiotensin receptor blockers can reduce arterial stiffness and improve arterial elasticity more than other antihypertensive drugs.
Aldosterone antagonist is not a routine antihypertensive drug, but as an important link in the renin-angiotensin-aldosterone system, its role in protecting blood vessels, improving vascular function, and reducing cardiovascular events is attracting more and more attention.
As for statins, in addition to lipid-lowering mechanism, mechanisms like anti-oxidative stress, anti-inflammatory, and mobilization of endothelial progenitor cells to repair vascular endothelial also play a role in anti-vascular aging.
Some new drugs that control risk factors, such as hypertension, hyperlipidemia, and diabetes, have also been shown to play a role in reducing arterial stiffness, treating endothelial dysfunction, and improving vascular reconstruction, which contribute to anti-vascular aging.
| Drugs improving endothelial function
The 
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